UNK HARMONYCA LIDOCAINE
Report
- Report Number
- 3005113652-2024-001104
- Event Type
- Injury
- Date Received
- May 28, 2024
- Date of Event
- March 26, 2024
- Report Date
- May 28, 2024
- Manufacturer
- ALLERGAN (PRINGY)
- Product Code
- LMH
- PMA / PMN Number
- -
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
CONTINUED D.10. CONCOMITANT THERAPIES: AMLODIPINE, FUROATE, MOMETASONE, CITALOPRAM, BETADERM, AND IRBESARTAN. CONTINUED H.6. HEALTH EFFECT - IMPACT CODES: F2303 CLARIFICATION TO H.6. TYPE OF INVESTIGATION CODE: THE FILLER WAS INJECTED INTO THE PATIENT AND IS NOT ACCESSIBLE FOR RETURN. THE SYRINGE WAS NOT RETURNED FOR EVALUATION. THE EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ABBVIE IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. THE EVENT OF HERNIA, DEEMED NOT DEVICE RELATED IS CONSIDERED AN UNEXPECTED ADVERSE DRUG EXPERIENCE.
HEALTHCARE PROFESSIONAL (HCP) REPORTED A CLINICAL PATIENT WAS INJECTED IN THE CHEEKS BILATERALLY WITH 2.3ML OF HARMONYCA LIDOCAINE. ABOUT ONE MONTH LATER THE PATIENT RECEIVED TOUCH-UP INJECTIONS WITH 1.1ML OF HARMONYCA LIDOCAINE. THE PATIENT WAS CONCOMITANTLY TREATED WITH TOPICAL PRE-TREATMENT ANESTHESIA AND CONCOMITANTLY TAKES AMLODIPINE, FUROATE, MOMETASONE, CITALOPRAM, BETADERM, AND IRBESARTAN. APPROXIMATELY SEVEN MONTHS AND A HALF AFTER THE TOUCH-UP INJECTIONS THE PATIENT EXPERIENCED NON DEVICE RELATED ¿HERNIA¿. ABOUT THREE WEEKS LATER, PATIENT WAS HOSPITALIZED AND UNDERWENT A HERNIA SURGERY. PATIENT WAS ALSO TREATED WITH HYDROMORPHONE. THE EVENT RESOLVED THE SAME DAY. THIS IS THE SAME EVENT AND THE SAME PATIENT REPORTED UNDER MDR ID# 3005113652-2024-0011046 (ABBVIE COMPLAINT # (B)(4). THIS MDR IS BEING SUBMITTED FOR THE FIRST INJECTION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1400203 | UNK HARMONYCA LIDOCAINE | IMPLANT, DERMAL, FOR AESTHETIC USE | LMH | ALLERGAN (PRINGY) | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Hospitalization| R | TOPICAL PRE-TREATMENT ANESTHESIA |